TKM Ebola (Protiva Biotherapeutics)
- Generic Name
- TKM Ebola (Protiva Biotherapeutics)
Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
- First Posted Date
- 2012-01-26
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Arbutus Biopharma Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT01518881
- Locations
- 🇺🇸
Cetero Research, Fargo, North Dakota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath